Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
15
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Roberts Michael J | VP, Business Development | 23 | $0 | $0 | 2014-06-23 |
| Oliveto Joseph | Vice President of Operations | 21 | $0 | $0 | 2014-06-23 |
| Schwieterman William D | Chief Medical Officer | 23 | $0 | $0 | 2014-06-23 |
| Schmidt Keith | Vice Pres. Marketing and Sales | 3 | $0 | $0 | 2014-06-23 |
| Rueckert William Dodge | Director | 15 | $0 | $0 | 2014-06-23 |
| Hewitt L Arthur | Chief Scientific Officer | 21 | $0 | $0 | 2014-06-23 |
| Riehle J Nick | Chief Financial Officer | 24 | $0 | $0 | 2014-06-23 |
| Clemens Kevan | Director | 18 | $0 | $0 | 2014-06-23 |
| WEISER MICHAEL | Director | 24 | $6.6K | $0 | 2014-06-23 |
| STOLL ROGER G PHD | Director | 16 | $0 | $0 | 2014-06-23 |
| AUSTIN JOSIAH T | 10% Owner | 7 | $0 | $1.87M | 2012-12-17 |
| El Coronado Holdings, LLC | 10% Owner | 6 | $289.7K | $640.9K | 2012-12-17 |
| LAU JOHNSON YIU NAM | Director | 2 | $10.5K | $0 | 2012-06-04 |
| Pedder Simon | Chief Executive Officer | 1 | $0 | $0 | 2012-01-25 |
| HARDMAN NORMAN PHD | Director | 1 | $0 | $0 | 2012-01-25 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Schwieterman William D | Chief Medical Officer | M Exercise deriv | 2014-06-23 | 2014-06-25 | 75,000 | — | $0 | 0 | SEC↗ |
| Schwieterman William D | Chief Medical Officer | M Exercise deriv | 2014-06-23 | 2014-06-25 | 50,000 | — | $0 | 0 | SEC↗ |
| Schwieterman William D | Chief Medical Officer | M Exercise deriv | 2014-06-23 | 2014-06-25 | 50,000 | — | $0 | 0 | SEC↗ |
| Schwieterman William D | Chief Medical Officer | M Exercise deriv | 2014-06-23 | 2014-06-25 | 30,000 | — | $0 | 0 | SEC↗ |
| Schwieterman William D | Chief Medical Officer | D To issuer deriv | 2014-06-23 | 2014-06-25 | 50,000 | — | $0 | 0 | SEC↗ |
| Schwieterman William D | Chief Medical Officer | M Exercise deriv | 2014-06-23 | 2014-06-25 | 10,000 | — | $0 | 0 | SEC↗ |
| Schwieterman William D | Chief Medical Officer | M Exercise deriv | 2014-06-23 | 2014-06-25 | 50,000 | — | $0 | 0 | SEC↗ |
| Schwieterman William D | Chief Medical Officer | M Exercise deriv | 2014-06-23 | 2014-06-25 | 50,000 | — | $0 | 0 | SEC↗ |
| Schwieterman William D | Chief Medical Officer | M Exercise deriv | 2014-06-23 | 2014-06-25 | 35,000 | — | $0 | 0 | SEC↗ |
| Riehle J Nick | Chief Financial Officer | M Exercise deriv | 2014-06-23 | 2014-06-25 | 68,923 | — | $0 | 0 | SEC↗ |
| Riehle J Nick | Chief Financial Officer | D To issuer deriv | 2014-06-23 | 2014-06-25 | 50,000 | — | $0 | 0 | SEC↗ |
| Riehle J Nick | Chief Financial Officer | M Exercise deriv | 2014-06-23 | 2014-06-25 | 50,000 | — | $0 | 0 | SEC↗ |
| Riehle J Nick | Chief Financial Officer | M Exercise deriv | 2014-06-23 | 2014-06-25 | 50,000 | — | $0 | 0 | SEC↗ |
| Riehle J Nick | Chief Financial Officer | M Exercise deriv | 2014-06-23 | 2014-06-25 | 50,000 | — | $0 | 0 | SEC↗ |
| Riehle J Nick | Chief Financial Officer | D To issuer deriv | 2014-06-23 | 2014-06-25 | 50,000 | $0.76 | $38.0K | 0 | SEC↗ |
| Riehle J Nick | Chief Financial Officer | M Exercise deriv | 2014-06-23 | 2014-06-25 | 50,000 | — | $0 | 0 | SEC↗ |
| Riehle J Nick | Chief Financial Officer | M Exercise deriv | 2014-06-23 | 2014-06-25 | 50,000 | — | $0 | 0 | SEC↗ |
| Riehle J Nick | Chief Financial Officer | M Exercise deriv | 2014-06-23 | 2014-06-25 | 50,000 | — | $0 | 0 | SEC↗ |
| Riehle J Nick | Chief Financial Officer | D To issuer deriv | 2014-06-23 | 2014-06-25 | 50,000 | $1.90 | $95.0K | 0 | SEC↗ |
| Riehle J Nick | Chief Financial Officer | D To issuer deriv | 2014-06-23 | 2014-06-25 | 50,000 | $1.79 | $89.5K | 0 | SEC↗ |
| Oliveto Joseph | President and CEO | M Exercise deriv | 2014-06-23 | 2014-06-25 | 150,000 | — | $0 | 0 | SEC↗ |
| Oliveto Joseph | President and CEO | D To issuer deriv | 2014-06-23 | 2014-06-25 | 75,000 | $0.81 | $60.8K | 0 | SEC↗ |
| Oliveto Joseph | President and CEO | D To issuer deriv | 2014-06-23 | 2014-06-25 | 50,000 | — | $0 | 0 | SEC↗ |
| Oliveto Joseph | President and CEO | M Exercise deriv | 2014-06-23 | 2014-06-25 | 150,000 | — | $0 | 0 | SEC↗ |
| Oliveto Joseph | President and CEO | D To issuer deriv | 2014-06-23 | 2014-06-25 | 110,000 | $1.79 | $196.9K | 0 | SEC↗ |
| Oliveto Joseph | President and CEO | M Exercise deriv | 2014-06-23 | 2014-06-25 | 50,000 | — | $0 | 0 | SEC↗ |
| Oliveto Joseph | President and CEO | M Exercise deriv | 2014-06-23 | 2014-06-25 | 50,000 | — | $0 | 0 | SEC↗ |
| Oliveto Joseph | President and CEO | M Exercise deriv | 2014-06-23 | 2014-06-25 | 50,000 | — | $0 | 0 | SEC↗ |
| Oliveto Joseph | President and CEO | M Exercise deriv | 2014-06-23 | 2014-06-25 | 40,000 | — | $0 | 0 | SEC↗ |
| Roberts Michael J | VP, Business Development | D To issuer deriv | 2014-06-23 | 2014-06-25 | 50,000 | $1.79 | $89.5K | 0 | SEC↗ |
| Roberts Michael J | VP, Business Development | D To issuer deriv | 2014-06-23 | 2014-06-25 | 35,000 | $4.94 | $172.9K | 0 | SEC↗ |
| Roberts Michael J | VP, Business Development | D To issuer deriv | 2014-06-23 | 2014-06-25 | 48,247 | $3.82 | $184.3K | 0 | SEC↗ |
| Roberts Michael J | VP, Business Development | D To issuer deriv | 2014-06-23 | 2014-06-25 | 50,000 | $3.48 | $174.0K | 0 | SEC↗ |
| Roberts Michael J | VP, Business Development | D To issuer deriv | 2014-06-23 | 2014-06-25 | 35,000 | $2.94 | $102.9K | 0 | SEC↗ |
| Roberts Michael J | VP, Business Development | D To issuer deriv | 2014-06-23 | 2014-06-25 | 50,000 | $1.90 | $95.0K | 0 | SEC↗ |
| Roberts Michael J | VP, Business Development | D To issuer deriv | 2014-06-23 | 2014-06-25 | 11,200 | $5.20 | $58.2K | 0 | SEC↗ |
| Roberts Michael J | VP, Business Development | D To issuer deriv | 2014-06-23 | 2014-06-25 | 35,000 | $0.76 | $26.6K | 0 | SEC↗ |
| Roberts Michael J | VP, Business Development | D To issuer deriv | 2014-06-23 | 2014-06-25 | 35,000 | $0.10 | $3.5K | 0 | SEC↗ |
| Roberts Michael J | VP, Business Development | D To issuer deriv | 2014-06-23 | 2014-06-25 | 50,000 | — | $0 | 0 | SEC↗ |
| Roberts Michael J | VP, Business Development | M Exercise deriv | 2014-06-23 | 2014-06-25 | 21,078 | — | $0 | 0 | SEC↗ |
| Roberts Michael J | VP, Business Development | M Exercise deriv | 2014-06-23 | 2014-06-25 | 50,000 | — | $0 | 0 | SEC↗ |
| Roberts Michael J | VP, Business Development | M Exercise deriv | 2014-06-23 | 2014-06-25 | 38,800 | — | $0 | 0 | SEC↗ |
| Schmidt Keith | Chief Commercial Officer | D To issuer deriv | 2014-06-23 | 2014-06-25 | 100,000 | $1.94 | $194.0K | 0 | SEC↗ |
| Clemens Kevan | Director | D To issuer deriv | 2014-06-23 | 2014-06-25 | 42,500 | $0.76 | $32.3K | 0 | SEC↗ |
| Clemens Kevan | Director | D To issuer deriv | 2014-06-23 | 2014-06-25 | 35,000 | $5.48 | $191.8K | 0 | SEC↗ |
| Clemens Kevan | Director | D To issuer deriv | 2014-06-23 | 2014-06-25 | 35,000 | $1.79 | $62.6K | 0 | SEC↗ |
| Clemens Kevan | Director | D To issuer deriv | 2014-06-23 | 2014-06-25 | 35,210 | $6.24 | $219.7K | 0 | SEC↗ |
| Clemens Kevan | Director | D To issuer deriv | 2014-06-23 | 2014-06-25 | 50,000 | $4.67 | $233.5K | 0 | SEC↗ |
| Clemens Kevan | Director | D To issuer deriv | 2014-06-23 | 2014-06-25 | 30,000 | $3.18 | $95.4K | 0 | SEC↗ |
| Clemens Kevan | Director | D To issuer deriv | 2014-06-23 | 2014-06-25 | 35,000 | $5.29 | $185.2K | 0 | SEC↗ |
| Clemens Kevan | Director | D To issuer deriv | 2014-06-23 | 2014-06-25 | 42,500 | — | $0 | 0 | SEC↗ |
| Clemens Kevan | Director | D To issuer deriv | 2014-06-23 | 2014-06-25 | 40,000 | $4.66 | $186.4K | 0 | SEC↗ |
| Clemens Kevan | Director | D To issuer deriv | 2014-06-23 | 2014-06-25 | 40,000 | $3.48 | $139.2K | 0 | SEC↗ |
| Clemens Kevan | Director | D To issuer deriv | 2014-06-23 | 2014-06-25 | 40,000 | — | $0 | 0 | SEC↗ |
| Clemens Kevan | Director | D To issuer deriv | 2014-06-23 | 2014-06-25 | 40,000 | $1.90 | $76.0K | 0 | SEC↗ |
| WEISER MICHAEL | Director | D To issuer deriv | 2014-06-23 | 2014-06-25 | 17,500 | $5.34 | $93.5K | 0 | SEC↗ |
| WEISER MICHAEL | Director | D To issuer deriv | 2014-06-23 | 2014-06-25 | 30,000 | $4.66 | $139.8K | 0 | SEC↗ |
| WEISER MICHAEL | Director | D To issuer deriv | 2014-06-23 | 2014-06-25 | 30,000 | $3.48 | $104.4K | 0 | SEC↗ |
| WEISER MICHAEL | Director | D To issuer deriv | 2014-06-23 | 2014-06-25 | 30,000 | — | $0 | 0 | SEC↗ |
| WEISER MICHAEL | Director | D To issuer deriv | 2014-06-23 | 2014-06-25 | 30,000 | $1.90 | $57.0K | 0 | SEC↗ |
| WEISER MICHAEL | Director | D To issuer deriv | 2014-06-23 | 2014-06-25 | 35,000 | $5.29 | $185.2K | 0 | SEC↗ |
| WEISER MICHAEL | Director | D To issuer deriv | 2014-06-23 | 2014-06-25 | 27,500 | $0.76 | $20.9K | 0 | SEC↗ |
| WEISER MICHAEL | Director | D To issuer deriv | 2014-06-23 | 2014-06-25 | 52,500 | $5.48 | $287.7K | 0 | SEC↗ |
| WEISER MICHAEL | Director | D To issuer deriv | 2014-06-23 | 2014-06-25 | 52,500 | $1.79 | $94.0K | 0 | SEC↗ |
| WEISER MICHAEL | Director | M Exercise deriv | 2014-06-23 | 2014-06-25 | 27,500 | — | $0 | 0 | SEC↗ |
| WEISER MICHAEL | Director | D To issuer deriv | 2014-06-23 | 2014-06-25 | 50,000 | $4.67 | $233.5K | 0 | SEC↗ |
| WEISER MICHAEL | Director | D To issuer deriv | 2014-06-23 | 2014-06-25 | 8,802 | $3.82 | $33.6K | 0 | SEC↗ |
| WEISER MICHAEL | Director | D To issuer deriv | 2014-06-23 | 2014-06-25 | 30,000 | $3.18 | $95.4K | 0 | SEC↗ |
| Rueckert William Dodge | Director | D To issuer deriv | 2014-06-23 | 2014-06-25 | 30,000 | $3.48 | $104.4K | 0 | SEC↗ |
| Rueckert William Dodge | Director | D To issuer deriv | 2014-06-23 | 2014-06-25 | 35,000 | $1.79 | $62.6K | 0 | SEC↗ |
| Rueckert William Dodge | Director | D To issuer deriv | 2014-06-23 | 2014-06-25 | 50,000 | $4.67 | $233.5K | 0 | SEC↗ |
| Rueckert William Dodge | Director | D To issuer deriv | 2014-06-23 | 2014-06-25 | 35,000 | $1.19 | $41.6K | 0 | SEC↗ |
| Rueckert William Dodge | Director | D To issuer deriv | 2014-06-23 | 2014-06-25 | 30,000 | — | $0 | 0 | SEC↗ |
| Rueckert William Dodge | Director | D To issuer deriv | 2014-06-23 | 2014-06-25 | 30,000 | $1.90 | $57.0K | 0 | SEC↗ |
| Rueckert William Dodge | Director | D To issuer deriv | 2014-06-23 | 2014-06-25 | 35,000 | $5.29 | $185.2K | 0 | SEC↗ |
| Rueckert William Dodge | Director | D To issuer deriv | 2014-06-23 | 2014-06-25 | 35,000 | $5.48 | $191.8K | 0 | SEC↗ |
| Hewitt L Arthur | Chief Scientific Officer | D To issuer deriv | 2014-06-23 | 2014-06-25 | 50,000 | $3.48 | $174.0K | 0 | SEC↗ |
| Hewitt L Arthur | Chief Scientific Officer | D To issuer deriv | 2014-06-23 | 2014-06-25 | 50,000 | $3.18 | $159.0K | 0 | SEC↗ |
| Hewitt L Arthur | Chief Scientific Officer | D To issuer deriv | 2014-06-23 | 2014-06-25 | 50,000 | $1.90 | $95.0K | 0 | SEC↗ |
| Hewitt L Arthur | Chief Scientific Officer | D To issuer deriv | 2014-06-23 | 2014-06-25 | 50,000 | $1.79 | $89.5K | 0 | SEC↗ |
| Hewitt L Arthur | Chief Scientific Officer | D To issuer deriv | 2014-06-23 | 2014-06-25 | 50,000 | $0.76 | $38.0K | 0 | SEC↗ |
| Hewitt L Arthur | Chief Scientific Officer | D To issuer deriv | 2014-06-23 | 2014-06-25 | 50,000 | — | $0 | 0 | SEC↗ |
| Hewitt L Arthur | Chief Scientific Officer | D To issuer deriv | 2014-06-23 | 2014-06-25 | 50,000 | — | $0 | 0 | SEC↗ |
| Hewitt L Arthur | Chief Scientific Officer | M Exercise deriv | 2014-06-23 | 2014-06-25 | 50,000 | — | $0 | 0 | SEC↗ |
| Hewitt L Arthur | Chief Scientific Officer | M Exercise deriv | 2014-06-23 | 2014-06-25 | 50,000 | — | $0 | 0 | SEC↗ |
| Hewitt L Arthur | Chief Scientific Officer | M Exercise deriv | 2014-06-23 | 2014-06-25 | 50,000 | — | $0 | 0 | SEC↗ |
| Hewitt L Arthur | Chief Scientific Officer | M Exercise deriv | 2014-06-23 | 2014-06-25 | 68,923 | — | $0 | 0 | SEC↗ |
| STOLL ROGER G PHD | Director | D To issuer deriv | 2014-06-23 | 2014-06-25 | 30,000 | $1.90 | $57.0K | 0 | SEC↗ |
| STOLL ROGER G PHD | Director | D To issuer deriv | 2014-06-23 | 2014-06-25 | 35,000 | $1.79 | $62.6K | 0 | SEC↗ |
| STOLL ROGER G PHD | Director | D To issuer deriv | 2014-06-23 | 2014-06-25 | 35,000 | $5.48 | $191.8K | 0 | SEC↗ |
| STOLL ROGER G PHD | Director | D To issuer deriv | 2014-06-23 | 2014-06-25 | 35,000 | $1.64 | $57.4K | 0 | SEC↗ |
| STOLL ROGER G PHD | Director | D To issuer deriv | 2014-06-23 | 2014-06-25 | 30,000 | $4.66 | $139.8K | 0 | SEC↗ |
| STOLL ROGER G PHD | Director | D To issuer deriv | 2014-06-23 | 2014-06-25 | 30,000 | $3.48 | $104.4K | 0 | SEC↗ |
| STOLL ROGER G PHD | Director | D To issuer deriv | 2014-06-23 | 2014-06-25 | 30,000 | — | $0 | 0 | SEC↗ |
| STOLL ROGER G PHD | Director | D To issuer deriv | 2014-06-23 | 2014-06-25 | 50,000 | $4.67 | $233.5K | 0 | SEC↗ |
| STOLL ROGER G PHD | Director | D To issuer deriv | 2014-06-23 | 2014-06-25 | 35,000 | $5.29 | $185.2K | 0 | SEC↗ |
| Schwieterman William D | Chief Medical Officer | M Exercise | 2014-06-23 | 2014-06-25 | 10,000 | $2.96 | $29.6K | 145,000 | SEC↗ |
| Schwieterman William D | Chief Medical Officer | M Exercise | 2014-06-23 | 2014-06-25 | 30,000 | $1.78 | $53.4K | 250,000 | SEC↗ |
| Schwieterman William D | Chief Medical Officer | M Exercise | 2014-06-23 | 2014-06-25 | 50,000 | $1.24 | $62.0K | 300,000 | SEC↗ |
| Schwieterman William D | Chief Medical Officer | M Exercise | 2014-06-23 | 2014-06-25 | 50,000 | $0.96 | $48.0K | 350,000 | SEC↗ |
| Schwieterman William D | Chief Medical Officer | D To issuer | 2014-06-23 | 2014-06-25 | 350,000 | — | $0 | 0 | SEC↗ |
| Schwieterman William D | Chief Medical Officer | M Exercise | 2014-06-23 | 2014-06-25 | 50,000 | $4.54 | $227.0K | 135,000 | SEC↗ |
| Schwieterman William D | Chief Medical Officer | M Exercise | 2014-06-23 | 2014-06-25 | 50,000 | $4.65 | $232.5K | 85,000 | SEC↗ |
| Schwieterman William D | Chief Medical Officer | M Exercise | 2014-06-23 | 2014-06-25 | 35,000 | $5.07 | $177.4K | 35,000 | SEC↗ |
| Schwieterman William D | Chief Medical Officer | U Tender | 2014-06-23 | 2014-06-25 | 130,592 | — | $0 | 0 | SEC↗ |
| Schwieterman William D | Chief Medical Officer | M Exercise | 2014-06-23 | 2014-06-25 | 75,000 | $2.82 | $211.5K | 220,000 | SEC↗ |
| Riehle J Nick | Chief Financial Officer | M Exercise | 2014-06-23 | 2014-06-25 | 50,000 | $6.50 | $325.0K | 50,000 | SEC↗ |
| Riehle J Nick | Chief Financial Officer | U Tender | 2014-06-23 | 2014-06-25 | 66,183 | — | $0 | 0 | SEC↗ |
| Riehle J Nick | Chief Financial Officer | M Exercise | 2014-06-23 | 2014-06-25 | 50,000 | $3.26 | $163.0K | 100,000 | SEC↗ |
| Riehle J Nick | Chief Financial Officer | M Exercise | 2014-06-23 | 2014-06-25 | 50,000 | $2.96 | $148.0K | 150,000 | SEC↗ |
| Riehle J Nick | Chief Financial Officer | M Exercise | 2014-06-23 | 2014-06-25 | 68,923 | $2.62 | $180.6K | 218,923 | SEC↗ |
| Riehle J Nick | Chief Financial Officer | M Exercise | 2014-06-23 | 2014-06-25 | 50,000 | $1.78 | $89.0K | 268,923 | SEC↗ |
| Riehle J Nick | Chief Financial Officer | M Exercise | 2014-06-23 | 2014-06-25 | 50,000 | $1.24 | $62.0K | 318,923 | SEC↗ |
| Riehle J Nick | Chief Financial Officer | M Exercise | 2014-06-23 | 2014-06-25 | 50,000 | $0.96 | $48.0K | 368,923 | SEC↗ |
| Riehle J Nick | Chief Financial Officer | D To issuer | 2014-06-23 | 2014-06-25 | 368,923 | — | $0 | 0 | SEC↗ |
| Oliveto Joseph | President and CEO | M Exercise | 2014-06-23 | 2014-06-25 | 150,000 | $0.96 | $144.0K | 490,000 | SEC↗ |
| Oliveto Joseph | President and CEO | D To issuer | 2014-06-23 | 2014-06-25 | 490,000 | — | $0 | 0 | SEC↗ |
| Oliveto Joseph | President and CEO | U Tender | 2014-06-23 | 2014-06-25 | 3,500 | — | $0 | 0 | SEC↗ |
| Oliveto Joseph | President and CEO | M Exercise | 2014-06-23 | 2014-06-25 | 40,000 | $4.65 | $186.0K | 40,000 | SEC↗ |
| Oliveto Joseph | President and CEO | M Exercise | 2014-06-23 | 2014-06-25 | 50,000 | $4.54 | $227.0K | 90,000 | SEC↗ |
| Oliveto Joseph | President and CEO | M Exercise | 2014-06-23 | 2014-06-25 | 50,000 | $2.96 | $148.0K | 140,000 | SEC↗ |
| Oliveto Joseph | President and CEO | M Exercise | 2014-06-23 | 2014-06-25 | 50,000 | $1.78 | $89.0K | 190,000 | SEC↗ |
| Oliveto Joseph | President and CEO | M Exercise | 2014-06-23 | 2014-06-25 | 150,000 | $1.24 | $186.0K | 340,000 | SEC↗ |
| Roberts Michael J | VP, Business Development | M Exercise | 2014-06-23 | 2014-06-25 | 38,800 | $1.24 | $48.1K | 38,800 | SEC↗ |
| Roberts Michael J | VP, Business Development | U Tender | 2014-06-23 | 2014-06-25 | 22,000 | — | $0 | 0 | SEC↗ |
| Roberts Michael J | VP, Business Development | M Exercise | 2014-06-23 | 2014-06-25 | 50,000 | $0.96 | $48.0K | 88,800 | SEC↗ |
| Roberts Michael J | VP, Business Development | M Exercise | 2014-06-23 | 2014-06-25 | 21,078 | $0.18 | $3.8K | 109,878 | SEC↗ |
| Roberts Michael J | VP, Business Development | D To issuer | 2014-06-23 | 2014-06-25 | 109,878 | — | $0 | 0 | SEC↗ |
| Clemens Kevan | Director | U Tender | 2014-06-23 | 2014-06-25 | 5,000 | — | $0 | 0 | SEC↗ |
| WEISER MICHAEL | Director | M Exercise | 2014-06-23 | 2014-06-25 | 27,500 | $6.50 | $178.8K | 27,500 | SEC↗ |
| WEISER MICHAEL | Director | D To issuer | 2014-06-23 | 2014-06-25 | 27,500 | — | $0 | 0 | SEC↗ |
| WEISER MICHAEL | Director | U Tender | 2014-06-23 | 2014-06-25 | 450,178 | — | $0 | 0 | SEC↗ |
| Rueckert William Dodge | Director | U Tender | 2014-06-23 | 2014-06-25 | 15,000 | — | $0 | 0 | SEC↗ |
| Rueckert William Dodge | Director | U Tender | 2014-06-23 | 2014-06-25 | 35,000 | — | $0 | 0 | SEC↗ |
| Hewitt L Arthur | Chief Scientific Officer | M Exercise | 2014-06-23 | 2014-06-25 | 50,000 | $0.96 | $48.0K | 218,923 | SEC↗ |
| Hewitt L Arthur | Chief Scientific Officer | M Exercise | 2014-06-23 | 2014-06-25 | 50,000 | $1.24 | $62.0K | 168,923 | SEC↗ |
| Hewitt L Arthur | Chief Scientific Officer | M Exercise | 2014-06-23 | 2014-06-25 | 50,000 | $1.78 | $89.0K | 118,923 | SEC↗ |
| Hewitt L Arthur | Chief Scientific Officer | M Exercise | 2014-06-23 | 2014-06-25 | 68,923 | $2.62 | $180.6K | 68,923 | SEC↗ |
| Hewitt L Arthur | Chief Scientific Officer | U Tender | 2014-06-23 | 2014-06-25 | 58,683 | — | $0 | 0 | SEC↗ |
| Hewitt L Arthur | Chief Scientific Officer | D To issuer | 2014-06-23 | 2014-06-25 | 218,923 | — | $0 | 0 | SEC↗ |
| STOLL ROGER G PHD | Director | U Tender | 2014-06-23 | 2014-06-25 | 40,000 | — | $0 | 0 | SEC↗ |
| Schmidt Keith | Chief Commercial Officer | A Award deriv | 2014-01-28 | 2014-01-30 | 100,000 | — | $0 | 100,000 | SEC↗ |
| WEISER MICHAEL | Director | A Award deriv | 2014-01-22 | 2014-01-24 | 52,500 | — | $0 | 52,500 | SEC↗ |
| Clemens Kevan | Director | A Award deriv | 2014-01-22 | 2014-01-24 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Rueckert William Dodge | Director | A Award deriv | 2014-01-22 | 2014-01-24 | 35,000 | — | $0 | 35,000 | SEC↗ |
| STOLL ROGER G PHD | Director | A Award deriv | 2014-01-22 | 2014-01-24 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Oliveto Joseph | President and CEO | A Award deriv | 2014-01-22 | 2014-01-24 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Riehle J Nick | Chief Financial Officer | A Award deriv | 2014-01-22 | 2014-01-24 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Hewitt L Arthur | Chief Scientific Officer | A Award deriv | 2014-01-22 | 2014-01-24 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Schwieterman William D | Chief Medical Officer | A Award deriv | 2014-01-22 | 2014-01-24 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Roberts Michael J | VP, Business Development | A Award deriv | 2014-01-22 | 2014-01-24 | 50,000 | — | $0 | 50,000 | SEC↗ |
| STOLL ROGER G PHD | Director | A Award deriv | 2013-04-15 | 2013-04-18 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Rueckert William Dodge | Director | A Award deriv | 2013-04-15 | 2013-04-18 | 50,000 | — | $0 | 50,000 | SEC↗ |
| WEISER MICHAEL | Director | A Award deriv | 2013-04-15 | 2013-04-18 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Clemens Kevan | Director | A Award deriv | 2013-04-15 | 2013-04-18 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Oliveto Joseph | Interim President and CEO | A Award deriv | 2013-01-07 | 2013-01-09 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Riehle J Nick | Chief Financial Officer | A Award deriv | 2013-01-07 | 2013-01-09 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Hewitt L Arthur | Chief Scientific Officer | A Award deriv | 2013-01-07 | 2013-01-09 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Clemens Kevan | Director | A Award deriv | 2013-01-07 | 2013-01-09 | 35,000 | — | $0 | 35,000 | SEC↗ |
| WEISER MICHAEL | Director | A Award deriv | 2013-01-07 | 2013-01-09 | 52,500 | — | $0 | 52,500 | SEC↗ |
| STOLL ROGER G PHD | Director | A Award deriv | 2013-01-07 | 2013-01-09 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Rueckert William Dodge | Director | A Award deriv | 2013-01-07 | 2013-01-09 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Schwieterman William D | Chief Medical Officer | A Award deriv | 2013-01-07 | 2013-01-09 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Roberts Michael J | VP, Business Development | A Award deriv | 2013-01-07 | 2013-01-09 | 50,000 | — | $0 | 50,000 | SEC↗ |
| AUSTIN JOSIAH T | 10% Owner | S Sale | 2012-12-17 | 2012-12-18 | 439,308 | $0.92 | $404.2K | 6,432,673 | SEC↗ |
| El Coronado Holdings, LLC | 10% Owner | S Sale | 2012-12-17 | 2012-12-19 | 439,308 | $0.92 | $404.2K | 6,432,673 | SEC↗ |
| AUSTIN JOSIAH T | 10% Owner | S Sale | 2012-12-14 | 2012-12-18 | 249,249 | $0.95 | $236.8K | 6,871,981 | SEC↗ |
| El Coronado Holdings, LLC | 10% Owner | S Sale | 2012-12-14 | 2012-12-19 | 249,249 | $0.95 | $236.8K | 6,871,981 | SEC↗ |
| AUSTIN JOSIAH T | 10% Owner | S Sale | 2012-12-12 | 2012-12-14 | 399,414 | $1.05 | $419.4K | 7,121,230 | SEC↗ |
| AUSTIN JOSIAH T | 10% Owner | S Sale | 2012-12-10 | 2012-12-11 | 139,653 | $1.05 | $146.6K | 7,520,644 | SEC↗ |
| AUSTIN JOSIAH T | 10% Owner | S Sale | 2012-12-07 | 2012-12-11 | 230,407 | $1.00 | $230.4K | 7,660,297 | SEC↗ |
| AUSTIN JOSIAH T | 10% Owner | S Sale | 2012-12-06 | 2012-12-07 | 235,009 | $1.07 | $251.5K | 7,890,704 | SEC↗ |
| AUSTIN JOSIAH T | 10% Owner | S Sale | 2012-12-05 | 2012-12-07 | 154,836 | $1.18 | $182.7K | 8,125,713 | SEC↗ |
| WEISER MICHAEL | Director | A Award deriv | 2012-07-30 | 2012-08-01 | 17,500 | — | $0 | 17,500 | SEC↗ |
| WEISER MICHAEL | Director | A Award deriv | 2012-07-23 | 2012-07-27 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Rueckert William Dodge | Director | A Award deriv | 2012-07-23 | 2012-07-27 | 35,000 | — | $0 | 35,000 | SEC↗ |
| STOLL ROGER G PHD | Director | A Award deriv | 2012-07-23 | 2012-07-27 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Clemens Kevan | Director | A Award deriv | 2012-07-23 | 2012-07-27 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Roberts Michael J | VP, Business Development | A Award deriv | 2012-07-09 | 2012-07-11 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Schwieterman William D | Chief Medical Officer | A Award deriv | 2012-07-09 | 2012-07-11 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Hewitt L Arthur | Chief Scientific Officer | A Award deriv | 2012-07-09 | 2012-07-11 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Riehle J Nick | Chief Financial Officer | A Award deriv | 2012-07-09 | 2012-07-11 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Oliveto Joseph | Interim President and CEO | A Award deriv | 2012-07-09 | 2012-07-11 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Roberts Michael J | VP, Business Development | A Award deriv | 2012-07-09 | 2012-07-19 | 50,000 | — | $0 | 50,000 | SEC↗ |
| WEISER MICHAEL | Director | P Buy | 2012-06-05 | 2012-06-06 | 100 | $1.32 | $132 | 445,278 | SEC↗ |
| WEISER MICHAEL | Director | P Buy | 2012-06-05 | 2012-06-06 | 4,900 | $1.32 | $6.5K | 450,178 | SEC↗ |
| LAU JOHNSON YIU NAM | Director | P Buy | 2012-06-04 | 2012-06-05 | 8,000 | $1.31 | $10.5K | 11,000 | SEC↗ |
| El Coronado Holdings, LLC | 10% Owner | P Buy | 2012-01-27 | 2012-01-30 | 13,900 | $4.46 | $62.0K | 8,301,049 | SEC↗ |
| El Coronado Holdings, LLC | 10% Owner | P Buy | 2012-01-27 | 2012-01-30 | 4,000 | $4.50 | $18.0K | 8,305,049 | SEC↗ |
| El Coronado Holdings, LLC | 10% Owner | P Buy | 2012-01-27 | 2012-01-30 | 4,000 | $4.43 | $17.7K | 8,287,149 | SEC↗ |
| Pedder Simon | Chief Executive Officer | A Award deriv | 2012-01-25 | 2012-01-27 | 175,000 | — | $0 | 175,000 | SEC↗ |
| Hewitt L Arthur | Chief Scientific Officer | A Award deriv | 2012-01-25 | 2012-01-27 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Riehle J Nick | Chief Financial Officer | A Award deriv | 2012-01-25 | 2012-01-27 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Schmidt Keith | Vice Pres. Marketing and Sal | A Award deriv | 2012-01-25 | 2012-01-27 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Oliveto Joseph | Vice President of Operations | A Award deriv | 2012-01-25 | 2012-01-27 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Schwieterman William D | Chief Medical Officer | A Award deriv | 2012-01-25 | 2012-01-27 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Roberts Michael J | VP, Business Development | A Award deriv | 2012-01-25 | 2012-01-27 | 50,000 | — | $0 | 50,000 | SEC↗ |
| LAU JOHNSON YIU NAM | Director | A Award deriv | 2012-01-25 | 2012-01-27 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Clemens Kevan | Director | A Award deriv | 2012-01-25 | 2012-01-27 | 40,000 | — | $0 | 40,000 | SEC↗ |
| WEISER MICHAEL | Director | A Award deriv | 2012-01-25 | 2012-01-27 | 30,000 | — | $0 | 30,000 | SEC↗ |
| STOLL ROGER G PHD | Director | A Award deriv | 2012-01-25 | 2012-01-27 | 30,000 | — | $0 | 30,000 | SEC↗ |
| HARDMAN NORMAN PHD | Director | A Award deriv | 2012-01-25 | 2012-01-27 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Rueckert William Dodge | Director | A Award deriv | 2012-01-25 | 2012-01-27 | 30,000 | — | $0 | 30,000 | SEC↗ |
| El Coronado Holdings, LLC | 10% Owner | P Buy | 2012-01-23 | 2012-01-24 | 40,000 | $4.80 | $192.0K | 8,283,149 | SEC↗ |
| STOLL ROGER G PHD | Director | G Gift | 2011-12-30 | 2012-01-27 | 12,000 | — | $0 | 40,000 | SEC↗ |